Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Taro to Announce Third Quarter Results on January 27, 2021


Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2020, after the close of market on Wednesday, January 27, 2021.

The release will be accessible on Taro's website at www.taro.com.

About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.


These press releases may also interest you

at 08:05
CG Life Specialty Agency The Market Element Relaunches as Element CG
CG Life specialty marketing communications agency Element CG, formerly The Market Element, today announced a brand relaunch to align more closely with its focus on supporting emerging life sciences and biopharma companies with scientific marketing...

at 08:05
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
Rubedo Life Sciences, a biotechnology company specializing in cellular senescence and anti-aging research, announced today a multi-year strategic partnership with German multinational beauty company Beiersdorf AG to develop innovative skin care...

at 08:03
OsteoRemedies® Obtains Expanded Indications for SPECTRUM® Dual Antibiotic Bone Cement
OsteoRemedies® LLC, an orthopedic company focused on providing simple solutions to complex disorders, has announced FDA clearance for expanded indications for the SPECTRUM® GV Bone Cement. The expanded indication covers the fixation of revision hip...

at 08:03
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Semler Scientific, Inc. , a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter...

at 08:03
Endevica Bio drug candidate shows success in weight loss in new study
Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent diet-induced obesity (DIO) rat study....

at 08:01
Pfizer Canada and McMaster University to foster health equity in vaccine science
During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and delivery of vaccines. Pfizer Canada's...

More news about Health...


News published on and distributed by: